how does glp-1 reduce inflammation The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury The anti-inflammatory and immunological properties

The primary endpoint of the study (the pre-determined measure of success for the study) was the changes in the MDS-UPDRS (part III) motor score and the change in non-motor symptoms (as assessed by the NMSS and MDRS-2) after 52 weeks of treatment ( Click here to read more about this study)

Both groups appear to have improved slightly

Probiotics support digestive health but do not produce weight loss comparable to pharmaceutical interventions

Get weekly science-backed tips on blood sugar, hormones, and nutrition tailored for Indian bodies

The information provided on this site is for informational purposes only and should not be considered medical advice or a substitute for professional healthcare

14) and no significant differences were observed with any of the drugs compared to placebo (Fig